Provided By GlobeNewswire
Last update: Apr 29, 2025
Two studies report favorable clinical outcomes and safety data for Renuvion® when used during procedures that include lipoabdominoplasty for the treatment of loose and lax skin
Read more at globenewswire.comNASDAQ:APYX (12/5/2025, 8:03:20 PM)
3.94
-0.09 (-2.23%)
Find more stocks in the Stock Screener


